Gene: UBP1
Official Full Name: upstream binding protein 1provided by HGNC
Gene Summary: Enables DNA-binding transcription activator activity, RNA polymerase II-specific and RNA polymerase II cis-regulatory region sequence-specific DNA binding activity. Involved in negative regulation of viral transcription and positive regulation of transcription by RNA polymerase II. Located in cytosol and nucleoplasm. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO34862 | UBP1 Knockout cell line (HeLa) | Human | UBP1 | 1:3~1:6 | Negative | Online Inquiry |
KO34863 | UBP1 Knockout cell line (HCT 116) | Human | UBP1 | 1:2~1:4 | Negative | Online Inquiry |
KO34864 | UBP1 Knockout cell line (HEK293) | Human | UBP1 | 1:3~1:6 | Negative | Online Inquiry |
KO34865 | UBP1 Knockout cell line (A549) | Human | UBP1 | 1:3~1:4 | Negative | Online Inquiry |
UBP1 Gene Knockout Cell Lines are expertly engineered cellular models that provide a platform for studying the functional role of the UBP1 gene in various biological processes. UBP1, known for its involvement in regulating protein ubiquitination and degradation, is crucial for maintaining cellular homeostasis and mediating responses to environmental stressors. The gene knockout methodology employed utilizes CRISPR-Cas9 technology to precisely eliminate UBP1 expression, resulting in cell lines that exhibit a loss-of-function phenotype ideal for dissecting the gene's contribution to cellular pathways.
The primary mechanism of action for these cell lines lies in the targeted disruption of UBP1, allowing researchers to investigate downstream effects on protein stability, signal transduction, and overall cellular behavior. By comparing the knockout cell lines to wild-type counterparts, scientists can readily assess the biochemical and phenotypic alterations resulting from UBP1 deficiency. These models are pivotal in research fields such as cancer biology, neurodegeneration, and pharmacology, where understanding the role of ubiquitin-mediated proteolysis can reveal new therapeutic targets.
One of the distinct advantages of UBP1 Gene Knockout Cell Lines is their specificity and reproducibility. Unlike other gene disruption techniques, CRISPR-Cas9 offers high efficiency and precision, minimizing off-target effects. Moreover, these lines come with extensive characterization data, ensuring reliable results in experiments, which is essential for obtaining publishable data. Researchers can also benefit from the versatility of these models; they can be used in a variety of assays, from gene expression studies to drug screening.
The value of UBP1 Gene Knockout Cell Lines extends well into clinical applications, offering insights that may inform therapeutic strategies in diseases associated with protein misfolding and degradation. For researchers and clinicians aiming to deepen their understanding of UBP1's functional dynamics, these cell lines represent an indispensable tool in their investigative arsenal.
With years of experience and a commitment to innovative biological products, our company specializes in providing high-quality, validated cell lines that address the evolving needs of the research community, firmly establishing our position at the forefront of genetic engineering technologies.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.